Specialized APIs and natural intermediates tailored for the growing Mexican biopharma manufacturing sector.
As the global pharmaceutical landscape shifts toward supply chain resilience, Mexico has emerged as a premier hub for Active Pharmaceutical Ingredients (APIs) and Intermediates. Driven by the USMCA (T-MEC) agreement and the "nearshoring" trend, the Mexican pharmaceutical market—currently valued at approximately $12 billion—is poised for explosive growth through 2030. Jiangxi Serum Pharma Industries Co., Ltd. stands at the forefront of this evolution, bridging high-tech Chinese manufacturing with the rigorous regulatory demands of the Mexican COFEPRIS (Federal Commission for the Protection against Sanitary Risk).
Post-pandemic strategies emphasize "China Plus One." Mexico's proximity to North American markets and its established manufacturing clusters in Mexico City, Jalisco, and Nuevo León make it an ideal partner for API integration and late-stage intermediate processing.
Mexico hosts over 20 of the world's top 25 pharmaceutical companies. The local industry is transitioning from simple generic assembly to complex molecule synthesis, creating an urgent demand for high-purity intermediates like Eucalyptus Oil and NMN.
Sustainability and Green Chemistry are no longer optional. The Mexican market is increasingly seeking bio-fermented proteins and plant-derived peptides that align with global ESG standards and consumer preferences for "natural" healthcare.
Jiangxi Serum Pharma Industries Co., Ltd. is a professional powerhouse in the supply of pharmaceutical and nutritional solutions. With nearly a decade of expertise, we specialize in the export of biological products, vaccines, Western medicines, and high-value intermediates. Our mission is to provide the Mexican industrial sector with reliable, cost-effective, and high-purity raw materials that meet international pharmacopoeia standards.
Serum Pharma is committed to the "Bio-Digital" revolution, integrating AI-driven synthesis with traditional excellence.
Our roadmap includes the deployment of secondary metabolites produced via precision fermentation. For the Mexico market, this means access to highly stable peptides and plant proteins like Mung Bean and Pea Protein Isolate that offer superior solubility and bioavailability.
To reduce manufacturing complexity for our Mexican partners, we offer customized Co-Crystallization of APIs. This improves the flowability and compression characteristics of raw materials, essential for high-speed tablet pressing and capsule filling in local facilities.
Understanding the "Last Mile" in Mexico's diverse geography, we are optimizing our cold-chain logistics for biological products and vaccines, ensuring 100% integrity from our labs to Mexico City or Monterrey hubs.
Customized nutrient blends for the Mexican functional food market.
Enhancing stability and solubility of complex active molecules.
Sustainable production of high-value peptides and proteins.
From pharmaceutical grade oils to advanced anti-aging molecules, explore our E-E-A-T verified catalog.
Understanding the shift from shark-liver to sustainable plant sources in the Mexican cosmetic and pharma industries.
Read More →
Why Dexamethasone Sodium Phosphate API remains essential for the Mexican public health system.
Read More →Eli Lilly's Foundayo™ (orforglipron) sets a record for fastest FDA approval. How this impacts the peptide supply chain in Latin America.
Read Full Analysis →Partner with a supplier that understands the technical, regulatory, and logistical nuances of the Mexican market.
Inquire Today
